Dasatinib 100 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FCS7B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,072
Award facts
- Contract value 100% obligated
- $50,072.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $50,072.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets (30-count packaging) on December 3, 2025, with completion scheduled for December 4, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency and other military healthcare systems, supplying a comprehensive range of brand-name and generic pharmaceuticals, vaccines, and medical supplies.
This delivery order supports the DLA Medical Supply Chain's ongoing need for oncology medications, specifically Dasatinib, which is used in cancer treatment regimens. AmerisourceBergen's extensive federal contracting portfolio demonstrates consistent capability to meet competitive procurement requirements, with prior awards ranging from nominal values to substantial orders exceeding $45,000. The firm's appointment as a pharmaceutical prime vendor reflects its role in maintaining critical pharmaceutical inventory across global military healthcare operations and supporting various federal agencies' medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26FCS7B?
SPE2DR26FCS7B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FCS7B worth?
The government has obligated $50,072 on SPE2DR26FCS7B.
Is contract SPE2DR26FCS7B an order under another contract?
Yes. SPE2DR26FCS7B is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCS7B competed?
The extent of competition for SPE2DR26FCS7B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award